A detailed history of Axq Capital, LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Axq Capital, LP holds 15,600 shares of TEVA stock, worth $262,236. This represents 0.05% of its overall portfolio holdings.

Number of Shares
15,600
Previous 15,300 1.96%
Holding current value
$262,236
Previous $160 Million 37.8%
% of portfolio
0.05%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$10.67 - $14.43 $3,201 - $4,329
300 Added 1.96%
15,600 $220 Million
Q4 2023

Feb 13, 2024

SELL
$8.12 - $10.63 $103,935 - $136,064
-12,800 Reduced 45.55%
15,300 $160 Million
Q3 2023

Nov 14, 2023

BUY
$7.48 - $10.7 $39,644 - $56,709
5,300 Added 23.25%
28,100 $287 Million
Q2 2023

Aug 11, 2023

BUY
$7.2 - $9.47 $6,847 - $9,005
951 Added 4.35%
22,800 $172 Million
Q1 2023

May 10, 2023

BUY
$8.36 - $11.37 $182,657 - $248,423
21,849 New
21,849 $193 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.7B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Axq Capital, LP Portfolio

Follow Axq Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Axq Capital, LP with notifications on news.